🚀 VC round data is live in beta, check it out!
LBX Pharmacy Valuation Multiples
Discover revenue and EBITDA valuation multiples for LBX Pharmacy and similar public comparables like Dis-Chem Pharmacies, Omnicell, Redcare Pharmacy, AiN Group and more.
LBX Pharmacy Overview
About LBX Pharmacy
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
Founded
2005
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$2B
LBX Pharmacy Financials
LBX Pharmacy reported last 12-month revenue of $3B and EBITDA of $319M.
In the same LTM period, LBX Pharmacy generated $1B in gross profit, $319M in EBITDA, and $99M in net income.
Revenue (LTM)
LBX Pharmacy P&L
In the most recent fiscal year, LBX Pharmacy reported revenue of $3B and EBITDA of $374M.
LBX Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 33% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $319M | XXX | $374M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $99M | XXX | $76M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $98M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
LBX Pharmacy Stock Performance
LBX Pharmacy has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
LBX Pharmacy's stock price is $2.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.2% | XXX | XXX | XXX | $0.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLBX Pharmacy Valuation Multiples
LBX Pharmacy trades at 0.6x EV/Revenue multiple, and 6.5x EV/EBITDA.
EV / Revenue (LTM)
LBX Pharmacy Financial Valuation Multiples
As of March 20, 2026, LBX Pharmacy has market cap of $2B and EV of $2B.
Equity research analysts estimate LBX Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
LBX Pharmacy has a P/E ratio of 16.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 6.5x | XXX | 5.5x | XXX | XXX | XXX |
| EV/EBIT | 11.8x | XXX | 11.8x | XXX | XXX | XXX |
| EV/Gross Profit | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| P/E | 16.7x | XXX | 21.8x | XXX | XXX | XXX |
| EV/FCF | 14.9x | XXX | 9.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified LBX Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
LBX Pharmacy Margins & Growth Rates
LBX Pharmacy's revenue in the last 12 month grew by 9%.
LBX Pharmacy's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
LBX Pharmacy's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
LBX Pharmacy Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | (16%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| S&M Expenses to Revenue | 22% | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
LBX Pharmacy Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Dis-Chem Pharmacies | XXX | XXX | XXX | XXX | XXX | XXX |
| Omnicell | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| AiN Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Create SD Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
LBX Pharmacy M&A Activity
LBX Pharmacy acquired XXX companies to date.
Last acquisition by LBX Pharmacy was on XXXXXXXX, XXXXX. LBX Pharmacy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by LBX Pharmacy
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLBX Pharmacy Investment Activity
LBX Pharmacy invested in XXX companies to date.
LBX Pharmacy made its latest investment on XXXXXXXX, XXXXX. LBX Pharmacy invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by LBX Pharmacy
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout LBX Pharmacy
| When was LBX Pharmacy founded? | LBX Pharmacy was founded in 2005. |
| Where is LBX Pharmacy headquartered? | LBX Pharmacy is headquartered in China. |
| Is LBX Pharmacy publicly listed? | Yes, LBX Pharmacy is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of LBX Pharmacy? | LBX Pharmacy trades under 603883 ticker. |
| When did LBX Pharmacy go public? | LBX Pharmacy went public in 2015. |
| Who are competitors of LBX Pharmacy? | LBX Pharmacy main competitors are Dis-Chem Pharmacies, Omnicell, Redcare Pharmacy, AiN Group. |
| What is the current market cap of LBX Pharmacy? | LBX Pharmacy's current market cap is $2B. |
| What is the current revenue of LBX Pharmacy? | LBX Pharmacy's last 12 months revenue is $3B. |
| What is the current revenue growth of LBX Pharmacy? | LBX Pharmacy revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of LBX Pharmacy? | Current revenue multiple of LBX Pharmacy is 0.6x. |
| Is LBX Pharmacy profitable? | Yes, LBX Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of LBX Pharmacy? | LBX Pharmacy's last 12 months EBITDA is $319M. |
| What is LBX Pharmacy's EBITDA margin? | LBX Pharmacy's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of LBX Pharmacy? | Current EBITDA multiple of LBX Pharmacy is 6.5x. |
| What is the current FCF of LBX Pharmacy? | LBX Pharmacy's last 12 months FCF is $138M. |
| What is LBX Pharmacy's FCF margin? | LBX Pharmacy's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of LBX Pharmacy? | Current FCF multiple of LBX Pharmacy is 14.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.